Denmark's Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity over the last few years with its GLP-1 agonist drugs
With the healthcare sector accounting for around 4% of global emissions – about the same as a small country – only an ecosystem-wide effort will succeed.
To celebrate International Women's Day, we speak to design engineer at Envair Technology Darina Shopova; general manager, UK & ROI at Healthcare Business of Merck Doina Ionescu; and vic
Novo Nordisk's rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates it will help drive obesity sales
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.
